Caplin Point Laboratories share news, announcements and annual reports
NSE: CAPLIPOINTBSE: 524742Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹2,362.80.
29 Oct: open ₹2,356.20, high ₹2,409.90, low ₹2,344.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18,061 Cr453rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 27.15
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.04
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 85,55750.9% delivered
Caplin Point Laboratories analyst meets
50 filed, newest first.
Jul 2026
30 Jul · Analysts
May 2026
22 May · Analysts
14 May · Analysts
7 May · Analysts
Jan 2026
29 Jan · Analysts
Oct 2025
29 Oct · Analysts
Jul 2025
30 Jul · Analysts
May 2025
7 May · Analysts
Jan 2025
31 Jan · Analysts
Dec 2024
9 Dec · Analysts
Oct 2024
30 Oct · Analysts
Aug 2024
1 Aug · Analysts
May 2024
9 May · Analysts
Feb 2024
2 Feb · Analysts
Nov 2023
3 Nov · Analysts
Sep 2023
13 Sep · Analysts
Aug 2023
3 Aug · Analysts
May 2023
22 May · Analysts
18 May · Analysts
Nov 2022
11 Nov · Analysts
Aug 2022
2 Aug · Analysts
May 2022
9 May · Analysts
Feb 2022
1 Feb · Analysts
Oct 2021
30 Oct · Analysts
Aug 2021
4 Aug · Analysts
May 2021
6 May · Analysts
Feb 2021
2 Feb · Analysts
Dec 2020
28 Dec · Analysts
21 Dec · Analysts
Nov 2020
20 Nov · Analysts
10 Nov · Analysts
Oct 2020
30 Oct · Analysts
9 Oct · Analysts
Sep 2020
30 Sep · Analysts
24 Sep · Analysts
17 Sep · Analysts
11 Sep · Analysts
4 Sep · Analysts
1 Sep · Analysts
Aug 2020
27 Aug · Analysts
21 Aug · Analysts
17 Aug · Analysts
3 Aug · Analysts
Jul 2020
2 Jul · Analysts
Mar 2020
26 Mar · Analysts
Jan 2019
31 Jan · Analysts
Nov 2016
11 Nov · Analysts